Atopy: a risk factor of refractory mycoplasma pneumoniae pneumonia?

Area of Science:

• Pediatric Pulmonology
• Infectious Diseases
• Allergy and Immunology

Background:

• Mycoplasma pneumoniae (MP) pneumonia is a common childhood respiratory infection.
• Understanding factors influencing MP pneumonia severity is crucial for effective treatment.
• The role of pathogen load and atopy in MP pneumonia outcomes requires further investigation.

Purpose of the Study:

• To examine the association between Mycoplasma pneumoniae DNA levels and clinical/laboratory features in children with MP pneumonia.
• To identify risk factors contributing to refractory MP pneumonia.

Main Methods:

• 95 children with MP pneumonia were categorized into high-MP-load (>10^6/mL) and low-MP-load (<=10^6/mL) groups based on bronchoalveolar lavage fluid (BALF) MP-DNA copies.
• Clinical data, allergy history, aeroallergen/food allergen skin tests, serum IgE, eosinophil cationic protein (ECP), and BALF cytokine levels (IL-4, IFN-γ, IL-8, TNF-α) were analyzed.

Main Results:

• The high-MP-load group showed a higher incidence of refractory MP pneumonia (72.7% vs 41.9%) compared to the low-MP-load group.
• Children with high MP loads had more extrapulmonary manifestations, lung consolidation, pleural effusion, and atopic conditions (allergy history, positive aeroallergen tests, elevated serum IgE/ECP).
• Significantly higher BALF IL-4 levels were observed in the high-MP-load group (p < 0.01), while IFN-γ, IL-8, and TNF-α levels did not differ significantly.

Conclusions:

• A high Mycoplasma pneumoniae load in the airway is associated with increased severity and refractory disease.
• Atopy appears to be a significant risk factor for the development and severity of refractory MP pneumonia.
• These findings highlight the interplay between pathogen load, host immune response (particularly IL-4), and atopic predisposition in MP pneumonia.